S. Küçükyurt Kaya, “Comparative prognostic performance of ELN 2022 and ELN 2024 risk classifications in a Turkish cohort of acute myeloid leukemia patients receiving hypomethylating agents and BCL-2 inhibitors”, Acta Medica, vol. 57, no. 2, pp. 157–165, Jun. 2026.